Imaging Hypoxic Myocardium.
- Author:
Sang Kyun BAE
1
Author Information
1. Department of Nuclear Medicine, Inje University College of Medicine, Busan, Korea. sbae@inje.ac.kr
- Publication Type:Review
- Keywords:
hypoxia;
nitroimidazole;
hibernating myocardium
- MeSH:
Anoxia;
Heart;
Ischemia;
Lung;
Myocardial Ischemia;
Myocardium*;
Oxygen;
Perfusion;
Radiopharmaceuticals
- From:Korean Journal of Nuclear Medicine
2005;39(2):141-145
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hypoxia (decreased tissue oxygen tension) is a component of many diseases such as tumors, cerebrovascular diseases and ischemic heart diseases. Although hypoxia can be secondary to a low inspired pO2 or a variety of lung disorders, the most common cause is ischemia due to an oxygen demand greater than the local oxygen supply. In the heart tissue, hypoxia is often observed in persistent low-flow states, such as hibernating myocardium. Direct "hot spot" imaging of myocardial tissue hypoxia is potentially of great clinical importance because it may provide a means of identifying dysfunctional chronically ischemic but viable hibernating myocardium. A series of radiopharmaceuticals that incorporate nitroimidazole moieties have been synthesized to detect decreased local tissue pO2. In contrast to agents that localize in proportion to perfusion, these agents concentrate in hypoxic tissue. However, the ideal agents are not developed yet and the progress is very slow. Furthermore, the research focus is on tumor hypoxia nowadays. This review introduces the myocardial hypoxia imaging with summarizing the development of radiopharmaceuticals.
